Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pleural effusions.

M Tattersall1

  • 1University of Sydney, New South Wales, Australia.

Current Opinion in Oncology
|August 1, 1992
PubMed
Summary
This summary is machine-generated.

Malignant pleural effusions in cancer patients can be managed with systemic or local treatments. Recent trials suggest bleomycin sulfate is a superior sclerosing agent compared to tetracycline for effusion control.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes of patients with non-melanoma solid tumours receiving self-funded pembrolizumab at Chris O'Brien Lifehouse.

Internal medicine journal·2016
Same author

Immigrants' perceptions of the quality of their cancer care: an Australian comparative study, identifying potentially modifiable factors.

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same author

Limb preservation surgery with extracorporeal irradiation in the management of malignant bone tumor: the oncological outcomes of 101 patients.

Annals of oncology : official journal of the European Society for Medical Oncology·2013
Same author

Cell-death by apoptosis following anticancer drug-treatment in-vitro.

International journal of oncology·2011
Same author

Prostaglandin F2-alpha receptor regulation in human uterine myocytes.

Molecular human reproduction·2008
Same author

Balloon tamponade for vaginal lacerations causing severe postpartum haemorrhage.

BJOG : an international journal of obstetrics and gynaecology·2007

Area of Science:

  • Oncology
  • Pulmonology
  • Thoracic Surgery

Background:

  • Malignant pleural effusions are common in cancer patients.
  • Optimal management strategies remain undefined.
  • Systemic therapy is effective for drug-sensitive tumors.

Purpose of the Study:

  • To compare the efficacy of different intrapleural therapies for malignant pleural effusions.
  • To evaluate bleomycin sulfate versus tetracycline as sclerosing agents.
  • To assess the benefit of mitoxantrone in conjunction with pleural tube drainage.

Main Methods:

  • Review of recent randomized trials on malignant pleural effusion management.
  • Comparison of sclerosing agents (bleomycin sulfate vs. tetracycline).
  • Evaluation of intrapleural therapy (mitoxantrone) combined with large-bore pleural tube placement during thoracoscopy.

Related Experiment Videos

Main Results:

  • Bleomycin sulfate demonstrated superiority over tetracycline as a sclerosing agent.
  • Mitoxantrone did not provide additional benefit when compared to large-bore pleural tube alone.
  • Current local treatments vary in drainage methods, tube duration, and intrapleural agents.

Conclusions:

  • Bleomycin sulfate is a preferred sclerosing agent for malignant pleural effusions.
  • Adding mitoxantrone to large-bore pleural tube drainage does not improve effusion control.
  • Further research is needed to define optimal management protocols for malignant pleural effusions.